Trastuzumab BS IV infusion 150mg “NK” is a biosimilar formulation of trastuzumab (genetical recombination), produced by Nippon Kayaku. This injectable product (YJ code: 4291442D2030) is supplied as 150mg per bottle, indicated for the treatment of HER2-positive breast cancer and metastatic gastric cancer.
Trastuzumab BS IV infusion 150mg “NK”
Need more detailed information?
Contact TASAKI PHARMA for inquiries about this medicine (English support available).
Contact us about this drug →